These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7100546)

  • 1. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
    Staiger J; Konrad-Graf S; Keil G
    Bibl Haematol; 1981; (47):252-7. PubMed ID: 7337665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with Arwin (author's transl)].
    Hess H; Keil-Kuri E; Marshall M
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1317-20. PubMed ID: 819792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H; Schmidt P; Hüttel E
    MMW Munch Med Wochenschr; 1978 Nov; 120(45):1501-4. PubMed ID: 101819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):387-92. PubMed ID: 786664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM
    Med Welt; 1975 Mar; 26(10):446-55. PubMed ID: 1123988
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of peptic ulcer in an inpatient angiologic patient sample].
    Creutzig A; Horstkotte H; Fischer M; Kleine P; Brunner G; Alexander K
    Leber Magen Darm; 1984 Jul; 14(4):161-3. PubMed ID: 6482641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic arterial occlusive disease: early and late results after semi-ambulatory treatment with serpent enzyme (Arvin)].
    Staiger J; Hausch W; Keil G; Konrad S
    Vasa; 1979; 8(4):314-9. PubMed ID: 543247
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases].
    Ehrly AM; Saeger-Lorenz K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():332-3. PubMed ID: 349931
    [No Abstract]   [Full Text] [Related]  

  • 16. A new approach in the treatment of peripheral arterial occlusions: defibrination with arvin.
    Ehringer H; Dudczak R; Lechner K
    Angiology; 1974 Apr; 25(4):279-89. PubMed ID: 4818725
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodilution combined with defibrinogenation.
    Böhme H; Everts B
    Bibl Haematol; 1981; (47):165-72. PubMed ID: 7039611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course].
    Heidrich H
    ZFA (Stuttgart); 1978 Nov; 54(32):1648-51. PubMed ID: 735320
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relations between the concentration of fibrinogen, thromboplastin time, thrombin time and reptilase time in patients treated with Arwin].
    Paar D; Klüken N
    Med Welt; 1975 Sep; 26(38):1700-1. PubMed ID: 1186461
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.